Epigenetic Regulation of Vascular Smooth Muscle Cell Function in Atherosclerosis

被引:0
作者
Hannes M. Findeisen
Florian K. Kahles
Dennis Bruemmer
机构
[1] University Hospital Aachen,Department of Internal Medicine I
[2] RWTH Aachen,Cardiology
[3] University of Kentucky College of Medicine,Division of Cardiovascular Medicine, Gill Heart Institute, Saha Cardiovascular Research Center
来源
Current Atherosclerosis Reports | 2013年 / 15卷
关键词
Smooth muscle cells; SMC; Epigenetic; Chromatin remodeling; Atherosclerosis; Histone modification; DNA-methylation;
D O I
暂无
中图分类号
学科分类号
摘要
Epigenetics involve heritable and acquired changes in gene transcription that occur independently of the DNA sequence. Epigenetic mechanisms constitute a hierarchic upper-level of transcriptional control through complex modifications of chromosomal components and nuclear structures. These modifications include, for example, DNA methylation or post-translational modifications of core histones; they are mediated by various chromatin-modifying enzymes; and ultimately they define the accessibility of a transcriptional complex to its target DNA. Integrating epigenetic mechanisms into the pathophysiologic concept of complex and multifactorial diseases such as atherosclerosis may significantly enhance our understanding of related mechanisms and provide promising therapeutic approaches. Although still in its infancy, intriguing scientific progress has begun to elucidate the role of epigenetic mechanisms in vascular biology, particularly in the control of smooth muscle cell phenotypes. In this review, we will summarize epigenetic pathways in smooth muscle cells, focusing on mechanisms involved in the regulation of vascular remodeling.
引用
收藏
相关论文
共 325 条
  • [1] Kouzarides T(2007)Chromatin modifications and their function Cell 128 693-705
  • [2] Dawson MA(2012)Cancer epigenetics: from mechanism to therapy Cell 150 12-27
  • [3] Kouzarides T(2011)Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification Cell 146 1016-28
  • [4] Tan M(2011)A decade of exploring the cancer epigenome - biological and translational implications Nat Rev Cancer 11 726-34
  • [5] Luo H(2005)DNA methylation and human disease Nat Rev Genet 6 597-610
  • [6] Lee S(2008)DNA methylation landscapes: provocative insights from epigenomics Nat Rev Genet 9 465-76
  • [7] Jin F(2009)Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 41 1350-3
  • [8] Yang JS(2002)DNA methylation patterns and epigenetic memory Genes Dev 16 6-21
  • [9] Baylin SB(2011)Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine Science 333 1300-3
  • [10] Jones PA(2009)Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1 Science 324 930-5